FDA Drug Application (203022) for PREGABALIN by APOTEX INC

Back to FDA Applications sponsored by APOTEX INC

Application Number203022
Product Number001
FormCAPSULE;ORAL
Dosage25MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePREGABALIN
Active IngredientPREGABALIN



Back to FDA Applications sponsored by APOTEX INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.